Investor Relations

Latest News

Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
View All News
View All News

Latest Presentation

Q3 2024 Presentation
View All Presentations

Recent Event

Third Quarter 2024 Results Q&A Call
View All Events

Latest Financial Results

Q3 2024

Quarter Ended Sep 30, 2024

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Report Links

Company Overview

Cryoport, Inc., is a global provider of innovative products and services to the fast-growing Cell & Gene Therapy industry - enabling the future of medicine for a new era of life sciences. With 50 strategic locations covering the Americas, EMEA (Europe, the Middle East and Africa) and APAC (Asia Pacific), Cryoport's global platform provides mission-critical bio-logistics, bio-storage, bio-processing, and cryogenic systems to the life sciences markets worldwide.

View Executive Team View Board of Directors

Stock Snapshot

IR Contacts

Headquarters

Cryoport, Inc.
112 Westwood Place
Suite 350
Brentwood, TN 37027

Investor Relations

Scott Eckstein
seckstein@kcsa.com

Todd Fromer
tfromer@kcsa.com

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place
8th Floor
New York, NY 10004
T: 212-509-4000